At the same time, Trox reduced the concentration of ROMO1 compared to untreated 8305C control cells, reducing the production of free radicals, as a consequence of the inflammatory state that favors the tumor microenvironment [45]. This evidence concerns the gene ROMO1 and neoplasm.